Banner Art
Text  Increase Text SizeDecrease Text Size

Drug Utilization Review (DUR) Board

The Drug Utilization Review (DUR) Board serves in an advisory capacity to the Department and makes recommendations regarding issues of drug utilization, provider education interventions, and application of standards. The Board meets once quarterly. The Board consists of nine members appointed by the Executive Director; four physicians, four pharmacists licensed and actively practicing in Colorado, and one non-voting pharmaceutical industry representative.


The DUR Board also determines the prior authorization criteria for drugs with special prescribing guidelines and the prior authorization criteria for non-preferred drugs, those that don't make the Preferred Drug List (PDL).


DUR Board Policies and Procedures


Presenting Testimony


Interested parties that would like to present testimony to the DUR Board must sign up at least 24 hours in advance by contacting Robert Lodge at 303-866-3105.


Potential DUR Board Members


The Department is currently accepting curriculum vitae from potential DUR Board members. If you are interested in serving or know someone who would be qualified please submit a CV along with a completed Conflict of Interest form to Robert Lodge, 1570 Grant St., Denver, CO 80203, or fax to 303-866-3590, Attn: Robert Lodge.


Meeting Schedule


225 East 16th Avenue - 1st Floor Conference Room

Denver, CO 80203

Closed Session:  6:00 p.m. - 7:00 p.m.

Open Session:  7:00 p.m. - 9:00 p.m.


February 25, 2014 Agenda / Minutes
November 19, 2013
Agenda / Minutes
August 20, 2013
Agenda / Minutes


May 21, 2013

Agenda / Minutes


February 19, 2013

Agenda / Minutes  
November 13, 2012
Agenda / Minutes


August 21, 2012

Agenda / Minutes


May 15, 2012

Agenda / Minutes


February 21, 2012

Agenda / Minutes